<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38893693</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1168</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14111168</ELocationID><Abstract><AbstractText><b>Background:</b> Long COVID, characterized by a persistent symptom spectrum following SARS-CoV-2 infection, poses significant health, social, and economic challenges. This review aims to consolidate knowledge on its epidemiology, clinical features, and underlying mechanisms to guide global responses; <b>Methods:</b> We conducted a literature review, analyzing peer-reviewed articles and reports to gather comprehensive data on long COVID's epidemiology, symptomatology, and management approaches; <b>Results:</b> Our analysis revealed a wide array of long COVID symptoms and risk factors, with notable demographic variability. The current understanding of its pathophysiology suggests a multifactorial origin yet remains partially understood. Emerging diagnostic criteria and potential therapeutic strategies were identified, highlighting advancements in long COVID management; <b>Conclusions:</b> This review highlights the multifaceted nature of long COVID, revealing a broad spectrum of symptoms, diverse risk factors, and the complex interplay of physiological mechanisms underpinning the condition. Long COVID symptoms and disorders will continue to weigh on healthcare systems in years to come. Addressing long COVID requires a holistic management strategy that integrates clinical care, social support, and policy initiatives. The findings underscore the need for increased international cooperation in research and health planning to address the complex challenges of long COVID. There is a call for continued refinement of diagnostic and treatment modalities, emphasizing a multidisciplinary approach to manage the ongoing and evolving impacts of the condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xiufang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Science Library, Chinese Academy of Sciences, Beijing 100190, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Information Resources Management, School of Economics and Management, University of Chinese Academy of Sciences, Beijing 100190, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Taizhou People's Hospital, Taizhou 225306, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Integrative Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Lizhen</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4977-7577</Identifier><AffiliationInfo><Affiliation>College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>Tim Q</ForeName><Initials>TQ</Initials><Identifier Source="ORCID">0000-0001-6403-2827</Identifier><AffiliationInfo><Affiliation>Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandy</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4849-775X</Identifier><AffiliationInfo><Affiliation>Indian Council of Forestry Research &amp; Education, Dehradun 248006, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongdou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Planetary Health and Food Security, School of Environment and Science, Griffith University, Nathan, Brisbane, QLD 4111, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Library, China Agricultural University (East Campus), 17 Qinghua East Road, Haidian District, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jiayao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Library, China Agricultural University (East Campus), 17 Qinghua East Road, Haidian District, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6010-9935</Identifier><AffiliationInfo><Affiliation>National Science Library, Chinese Academy of Sciences, Beijing 100190, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Information Resources Management, School of Economics and Management, University of Chinese Academy of Sciences, Beijing 100190, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tong</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6643-6411</Identifier><AffiliationInfo><Affiliation>School of Agriculture and Food Sustainability, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus risk factors</Keyword><Keyword MajorTopicYN="N">counter-measure</Keyword><Keyword MajorTopicYN="N">multisystem impact</Keyword><Keyword MajorTopicYN="N">public health response</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38893693</ArticleId><ArticleId IdType="pmc">PMC11171614</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14111168</ArticleId><ArticleId IdType="pii">diagnostics14111168</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization   [(accessed on 16 March 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Trihandini I., Muhtar M. The effect of long-haul COVID-19 toward domains of the health-related quality of life among recovered hospitalized patients. Front. Public Health. 2023;11:1068127. doi: 10.3389/fpubh.2023.1068127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1068127</ArticleId><ArticleId IdType="pmc">PMC10434763</ArticleId><ArticleId IdType="pubmed">37601220</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Shetty A., Delanerolle G., Zeng Y., Zhang Y., Raymont V., Rathod S., Halabi S., Elliot K., Shi J.Q. A systematic review and meta-analysis of long COVID symptoms. Syst. Rev. 2023;12:88. doi: 10.1186/s13643-023-02250-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowyer R.C., Huggins C., Toms R., Shaw R.J., Hou B., Thompson E.J., Kwong A.S., Williams D.M., Kibble M., Ploubidis G.B. Characterising patterns of COVID-19 and long COVID symptoms: Evidence from nine UK longitudinal studies. Eur. J. Epidemiol. 2023;38:199&#x2013;210. doi: 10.1007/s10654-022-00962-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00962-6</ArticleId><ArticleId IdType="pmc">PMC9860244</ArticleId><ArticleId IdType="pubmed">36680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W., Yamada K., Kawai R., Imai T., Kawamoto K., Uji M., Kanda H., Takada M., Ohno Y., Ohtani H., et al. A cross-sectional, multicenter survey of the prevalence and risk factors for Long COVID. Sci. Rep. 2022;12:22413. doi: 10.1038/s41598-022-25398-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25398-6</ArticleId><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>Damant R.W., Rourke L., Cui Y., Lam G.Y., Smith M.P., Fuhr D.P., Tay J.K., Varughese R.A., Laratta C.R., Lau A., et al. Reliability and validity of the post COVID-19 condition stigma questionnaire: A prospective cohort study. eClinicalMedicine. 2023;55:101755. doi: 10.1016/j.eclinm.2022.101755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101755</ArticleId><ArticleId IdType="pmc">PMC9694932</ArticleId><ArticleId IdType="pubmed">36447641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Li Y., Yue Y., Yuan C., Kang J.H., Chavarro J.E., Bhupathiraju S.N., Roberts A.L. Adherence to Healthy Lifestyle Prior to Infection and Risk of Post-COVID-19 Condition. JAMA Intern. Med. 2023;183:232&#x2013;241. doi: 10.1001/jamainternmed.2022.6555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.6555</ArticleId><ArticleId IdType="pmc">PMC9989904</ArticleId><ArticleId IdType="pubmed">36745445</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Sampaio V.S., Ozahata M.C., Lopes R., Brito A.F., Bragatte M., Kalil J., Miraglia J.L., Malheiro D.T., Yang G., et al. Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020&#x2013;2022. Infect. Control Hosp. Epidemiol. 2023;44:1972&#x2013;1978. doi: 10.1017/ice.2023.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.95</ArticleId><ArticleId IdType="pmc">PMC10755155</ArticleId><ArticleId IdType="pubmed">37272468</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A., Iqbal K., Ali S.A., Azim D., Farid E., Baig M.D., Arif T.B., Raza M. The COVID-19 sequelae: A cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13:e13080. doi: 10.7759/cureus.13080.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13080</ArticleId><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Martinez L., Karten J., Kritzer M.D., Josephy-Hernandez S., Kim D., Newhouse A., Pasinski M., Praschan N., Razafsha M., Rubin D.B., et al. Post-Acute Sequelae of SARS-CoV-2 Infection: A Descriptive Clinical Study. J. Neuropsychiatry Clin. Neurosci. 2022;34:393&#x2013;405. doi: 10.1176/appi.neuropsych.21070193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.21070193</ArticleId><ArticleId IdType="pubmed">35686346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick D., Goyal L., Chourasia P., Zapata M.R., Yashi K., Surani S. COVID-19 induced postural orthostatic tachycardia syndrome (POTS): A review. Cureus. 2023;15:e36955. doi: 10.7759/cureus.36955.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36955</ArticleId><ArticleId IdType="pmc">PMC10065129</ArticleId><ArticleId IdType="pubmed">37009342</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis Carneiro D., Rocha I., Habek M., Helbok R., Sellner J., Struhal W., Wenning G., Fanciulli A. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection&#x2014;A systematic review. Eur. J. Neurol. 2023;30:1528&#x2013;1539. doi: 10.1111/ene.15714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15714</ArticleId><ArticleId IdType="pubmed">36694382</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry M., Bornstein S., Nagaraj N., Sardon G.A., Jr., Castel A., Vyas A., McDonnell K., Agneshwar M., Wilkinson A., Goldman L. Postacute Sequelae of SARS-CoV-2 in University Setting. Emerg. Infect. Dis. 2023;29:519&#x2013;527. doi: 10.3201/eid2903.221522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2903.221522</ArticleId><ArticleId IdType="pmc">PMC9973677</ArticleId><ArticleId IdType="pubmed">36703253</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskett W.I., Qureshi A.I., Shyu D., Armer J.M., Shyu C.-R. COVID-Specific Long-term Sequelae in Comparison to Common Viral Respiratory Infections: An Analysis of 17,487 Infected Adult Patients. Open Forum Infect. Dis. 2022;10:ofac683. doi: 10.1093/ofid/ofac683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac683</ArticleId><ArticleId IdType="pmc">PMC9846186</ArticleId><ArticleId IdType="pubmed">36686632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X., Cao S., Lee A.S., Manohar M., Sindher S.B., Ahuja N., Artandi M., Blish C.A., Blomkalns A.L., Chang I., et al. Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome. JCI Insight. 2022;7:e156713. doi: 10.1172/jci.insight.156713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.156713</ArticleId><ArticleId IdType="pmc">PMC9310538</ArticleId><ArticleId IdType="pubmed">35801588</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., de Lamballerie X., Blanch&#xe9; H., Deleuze J.-F., Gouraud C. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 26 January 2023)].  Available online:  https://www.umu.se/en/news/research-to-spread-light-on-long-covid-uncertainties_11713455/</Citation></Reference><Reference><Citation>Song Z., Giuriato M. Demographic and Clinical Factors Associated with Long COVID. Health Aff. 2023;42:433&#x2013;442. doi: 10.1377/hlthaff.2022.00991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2022.00991</ArticleId><ArticleId IdType="pubmed">36877912</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman J.D., Atyeo C., Zur Y., Cook C.E., Patel N.J., Vanni K.M., Kowalski E.N., Qian G., Srivatsan S., Shadick N.A., et al. Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases. Sci. Transl. Med. 2023;15:eadf6598. doi: 10.1126/scitranslmed.adf6598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.adf6598</ArticleId><ArticleId IdType="pmc">PMC10764151</ArticleId><ArticleId IdType="pubmed">37672567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S., de Oliveira J&#xfa;nior G.N., Sarti F.M., Filho W.J., Longobardi I., Turri J.A.O., Shinjo S.K., Ferriolli E., Avelino-Silva T.J., Busse A.L., et al. Acute Muscle Mass Loss Predicts Long-Term Fatigue, Myalgia, and Health Care Costs in COVID-19 Survivors. J. Am. Med. Dir. Assoc. 2023;24:10&#x2013;16. doi: 10.1016/j.jamda.2022.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2022.11.013</ArticleId><ArticleId IdType="pmc">PMC9682050</ArticleId><ArticleId IdType="pubmed">36493804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Quan L., Chavarro J.E., Slopen N., Kubzansky L.D., Koenen K.C., Kang J.H., Weisskopf M.G., Branch-Elliman W., Roberts A.L. Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection with Risk of Post-COVID-19 Conditions. JAMA Psychiatry. 2022;79:1081&#x2013;1091. doi: 10.1001/jamapsychiatry.2022.2640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Zhang L., Elbeji A., Wilmes P., Oustric P., Staub T., Nazarov P.V., Ollert M., Fagherazzi G. Long COVID Symptomatology after 12 Months and Its Impact on Quality of Life according to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infect Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of Long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins F.R., Govender M., Svanberg C., Nordgren J., Waller H., Nilsdotter-Augustinsson A., Henningsson A.J., Hagbom M., Sjowall J., Nystrom S., et al. Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19. Front. Immunol. 2022;13:1082912. doi: 10.3389/fimmu.2022.1082912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1082912</ArticleId><ArticleId IdType="pmc">PMC9846644</ArticleId><ArticleId IdType="pubmed">36685582</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K.M., Watson R.O., Schneider J.M., Neff C.P., Yamada E., Zhang M., Campbell T.B., Falta M.T., Jolley S.E., Fontenot A.P., et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisk L.E., Gottlieb M.A., Spatz E.S., Yu H., Wang R.C., Slovis B.H., Saydah S., Plumb I.D., O&#x2019;Laughlin K.N., Montoy J.C.C., et al. Association of Initial SARS-CoV-2 Test Positivity with Patient-Reported Well-being 3 Months after a Symptomatic Illness. JAMA Netw. Open. 2022;5:e2244486. doi: 10.1001/jamanetworkopen.2022.44486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.44486</ArticleId><ArticleId IdType="pmc">PMC9716377</ArticleId><ArticleId IdType="pubmed">36454572</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Badran B.W., Huffman S.M., Dancy M., Austelle C.W., Bikson M., Kautz S.A., George M.S. A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1716096/v1. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1716096/v1</ArticleId><ArticleId IdType="pmc">PMC9402278</ArticleId><ArticleId IdType="pubmed">36002874</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;9:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Colzato L.S., Elmers J., Beste C., Hommel B. A Prospect to Ameliorate Affective Symptoms and to Enhance Cognition in Long COVID Using Auricular Transcutaneous Vagus Nerve Stimulation. J. Clin. Med. 2023;12:1198. doi: 10.3390/jcm12031198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12031198</ArticleId><ArticleId IdType="pmc">PMC9917620</ArticleId><ArticleId IdType="pubmed">36769845</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral Neuropathy Evaluations of Patients with Prolonged Long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kervevan J., Staropoli I., Slama D., Jeger-Madiot R., Donnadieu F., Planas D., Pietri M.P., Loghmari-Bouchneb W., Alaba Tanah M., Robinot R., et al. Divergent adaptive immune responses define two types of long COVID. Front. Immunol. 2023;14:1221961. doi: 10.3389/fimmu.2023.1221961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1221961</ArticleId><ArticleId IdType="pmc">PMC10408302</ArticleId><ArticleId IdType="pubmed">37559726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubankova M., Hohberger B., Hoffmanns J., Furst J., Herrmann M., Guck J., Krater M. Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 2021;120:2838&#x2013;2847. doi: 10.1016/j.bpj.2021.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Br&#xfc;ningk S.C., Hoch T., Fan B., Muzio G., Thompson R.C., Ceglarek L., Meledin R., Westermann P., Emmenegger M., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long COVID. Science. 2024;383:eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., Connolly R., Brennan D., Laffan A., O&#x2019;Keeffe E., Zaporojan L., O&#x2019;Callaghan J., Thomson B., Connolly E., Argue R., et al. Blood&#x2013;brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 2024;27:421&#x2013;432. doi: 10.1038/s41593-024-01576-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Saladino V., Algeri D., Auriemma V. The psychological and social impact of COVID-19: New perspectives of well-being. Front. Psychol. 2020;11:577684. doi: 10.3389/fpsyg.2020.577684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.577684</ArticleId><ArticleId IdType="pmc">PMC7561673</ArticleId><ArticleId IdType="pubmed">33132986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali I., Alharbi O.M. COVID-19: Disease, management, treatment, and social impact. Sci. Total Environ. 2020;728:138861. doi: 10.1016/j.scitotenv.2020.138861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.138861</ArticleId><ArticleId IdType="pmc">PMC7175909</ArticleId><ArticleId IdType="pubmed">32344226</ArticleId></ArticleIdList></Reference><Reference><Citation>Long E., Patterson S., Maxwell K., Blake C., P&#xe9;rez R.B., Lewis R., McCann M., Riddell J., Skivington K., Wilson-Lowe R. COVID-19 pandemic and its impact on social relationships and health. J. Epidemiol. Community Health. 2022;76:128&#x2013;132. doi: 10.1136/jech-2021-216690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2021-216690</ArticleId><ArticleId IdType="pmc">PMC8380476</ArticleId><ArticleId IdType="pubmed">34413184</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wambeke E., Bezler C., Kasprowicz A.M., Charles A.L., Andres E., Geny B. Two-Years Follow-Up of Symptoms and Return to Work in Complex Post-COVID-19 Patients. J. Clin. Med. 2023;12:741. doi: 10.3390/jcm12030741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12030741</ArticleId><ArticleId IdType="pmc">PMC9917586</ArticleId><ArticleId IdType="pubmed">36769389</ArticleId></ArticleIdList></Reference><Reference><Citation>Aburto J.M., Scholey J., Kashnitsky I., Zhang L., Rahal C., Missov T.I., Mills M.C., Dowd J.B., Kashyap R. Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: A population-level study of 29 countries. Int. J. Epidemiol. 2022;51:63&#x2013;74. doi: 10.1093/ije/dyab207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab207</ArticleId><ArticleId IdType="pmc">PMC8500096</ArticleId><ArticleId IdType="pubmed">34564730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Chatfield D.A., Mphil A.M., Jolly A., Trender W., Hellyer P.J., Giovane M.D., Newcombe V.F.J., Outtrim J.G., Warne B., et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. eClinicalMedicine. 2022;47:101417. doi: 10.1016/j.eclinm.2022.101417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shi L., Jiang Z., Zeng N., Mei H., Lu Y., Yang J., Jin F., Ni S., Wu S., et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol. Psychiatry. 2023;28:1793&#x2013;1801. doi: 10.1038/s41380-023-01951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Suran M. Long COVID Linked with Unemployment in New Analysis. JAMA. 2023;329:701&#x2013;702. doi: 10.1001/jama.2023.0157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.0157</ArticleId><ArticleId IdType="pubmed">36790796</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 30 August 2022)].  Available online:  https://www.weforum.org/agenda/2022/08/long-covid-work-economy-united-states-health.</Citation></Reference><Reference><Citation> [(accessed on 9 May 2022)].  Available online:  https://www.bankofengland.co.uk/speech/2022/may/michael-saunders-speech-at-the-resolution-foundation-event.</Citation></Reference><Reference><Citation> [(accessed on 26 July 2021)]; Available online:  https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html#footnote3_25o93ze.</Citation></Reference><Reference><Citation>Hussain Z., Rizvi L.J., Sheikh H. The Equality Act (2010)-pre-and post-pandemic historic development on equality and discrimination issues for employers: Review of literature. Int. J. Law Manag. 2022;64:168&#x2013;183. doi: 10.1108/IJLMA-03-2021-0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/IJLMA-03-2021-0067</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 30 June 2022)].  Available online:  https://www.sydney.edu.au/news-opinion/news/2022/06/30/long-covid-presents-a-major-health-challenge-how-can-australia-b.html.</Citation></Reference><Reference><Citation> [(accessed on 16 December 2022)].  Available online:  https://www.pennmedicine.org/for-health-care-professionals/for-physicians/covid-information/post-covid19-assessment-and-recovery-clinic-at-penn.</Citation></Reference><Reference><Citation> [(accessed on 13 January 2023)].  Available online:  http://news.china.com.cn/2023-01/13/content_85058563.html.</Citation></Reference><Reference><Citation> [(accessed on 14 December 2022)].  Available online:  https://www.canada.ca/en/public-health/news/2022/12/government-of-canada-welcomes-task-force-report-on-post-covid-19-condition.html.</Citation></Reference><Reference><Citation>Gandjour A. Long COVID: Costs for the German economy and health care and pension system. BMC Health Serv. Res. 2023;23:641. doi: 10.1186/s12913-023-09601-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-09601-6</ArticleId><ArticleId IdType="pmc">PMC10266873</ArticleId><ArticleId IdType="pubmed">37316880</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 18 February 2021)].  Available online:  https://www.ukri.org/news/18-5-million-to-tackle-long-covid-in-the-community/</Citation></Reference><Reference><Citation> [(accessed on 30 March 2022)].  Available online:  https://www.ukri.org/news/uk-japanese-collaboration-to-address-covid-19-challenges/</Citation></Reference><Reference><Citation> [(accessed on 10 May 2024)]; Available online:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10887786/</Citation></Reference><Reference><Citation> [(accessed on 16 December 2022)]; Available online:  https://www.aihw.gov.au/getmedia/9592f439-9b96-4589-a55d-6b04e262e5e1/aihw-phe-318.pdf?v=20230605184446&amp;inline=true.</Citation></Reference><Reference><Citation>Lu J.Y., Wilson J., Hou W., Fleysher R., Herold B.C., Herold K.C., Duong T.Q. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: Comparison with influenza. eBioMedicine. 2023;90:104487. doi: 10.1016/j.ebiom.2023.104487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104487</ArticleId><ArticleId IdType="pmc">PMC9970376</ArticleId><ArticleId IdType="pubmed">36857969</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu A.Y., Wang S.H., Duong T.Q. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: A retrospective cohort study. BMJ Open Diabetes Res. Care. 2023;11:e003257. doi: 10.1136/bmjdrc-2022-003257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2022-003257</ArticleId><ArticleId IdType="pmc">PMC10276968</ArticleId><ArticleId IdType="pubmed">37295808</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang V., Fisher M., Hou W., Zhang L., Duong T.Q. Incidence of New-Onset Hypertension Post-COVID-19: Comparison with Influenza. Hypertension. 2023;80:2135&#x2013;2148. doi: 10.1161/HYPERTENSIONAHA.123.21174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.123.21174</ArticleId><ArticleId IdType="pubmed">37602375</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.Y., Boparai M.S., Shi C., Henninger E.M., Rangareddy M., Veeraraghavan S., Mirhaji P., Fisher M.C., Duong T.Q. Long-term outcomes of COVID-19 survivors with hospital AKI: Association with time to recovery from AKI. Nephrol. Dial. Transplant. 2023;38:2160&#x2013;2169. doi: 10.1093/ndt/gfad020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfad020</ArticleId><ArticleId IdType="pubmed">36702551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhao Y., Wang J., Zheng X., Xu D., Lv J., Yang L. Long-term renal outcomes of patients with COVID-19: A meta-analysis of observational studies. J. Nephrol. 2023;36:2441&#x2013;2456. doi: 10.1007/s40620-023-01731-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-023-01731-8</ArticleId><ArticleId IdType="pubmed">37787893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zhou X., Chen Y., Wang L., Zhu B., Jiang Y., Bu P., Liu W., Li D., Li Y., et al. Changes in Home Blood Pressure Monitored Among Elderly Patients with Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application. Circ. Cardiovasc. Qual. Outcomes. 2021;14:e007098. doi: 10.1161/CIRCOUTCOMES.120.007098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.120.007098</ArticleId><ArticleId IdType="pmc">PMC8136456</ArticleId><ArticleId IdType="pubmed">34003685</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotanda H., Liyanage-Don N., Moran A.E., Krousel-Wood M., Green J.B., Zhang Y., Nuckols T.K. Changes in Blood Pressure Outcomes Among Hypertensive Individuals during the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations. Hypertension. 2022;79:2733&#x2013;2742. doi: 10.1161/HYPERTENSIONAHA.122.19861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.122.19861</ArticleId><ArticleId IdType="pmc">PMC9640259</ArticleId><ArticleId IdType="pubmed">36317526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouwmans P., Malahe S.R.K., Messchendorp A.L., Vart P., Imhof C., Sanders J.F., Gansevoort R.T., de Vries A.P.J., Abrahams A.C., Bemelman F.J., et al. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study. Int. J. Infect. Dis. 2024;142:106990. doi: 10.1016/j.ijid.2024.106990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2024.106990</ArticleId><ArticleId IdType="pubmed">38428480</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadifar M., Abhari A.P., Nouri H., Salari M., Maleki S., Amin A., Sedaghat N. Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC Neurol. 2022;22:64. doi: 10.1186/s12883-022-02590-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02590-9</ArticleId><ArticleId IdType="pmc">PMC8861623</ArticleId><ArticleId IdType="pubmed">35193507</ArticleId></ArticleIdList></Reference><Reference><Citation>Etemadifar M., Sedaghat N., Aghababaee A., Kargaran P.K., Maracy M.R., Ganjalikhani-Hakemi M., Rayani M., Abhari A.P., Khorvash R., Salari M., et al. COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? Mult. Scler. Relat. Disord. 2021;51:102915. doi: 10.1016/j.msard.2021.102915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.102915</ArticleId><ArticleId IdType="pmc">PMC7980521</ArticleId><ArticleId IdType="pubmed">33799284</ArticleId></ArticleIdList></Reference><Reference><Citation>Montini F., Nozzolillo A., Tedone N., Mistri D., Rancoita P.M., Zanetta C., Mandelli A., Furlan R., Moiola L., Martinelli V., et al. COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study. J. Neurol. Neurosurg. Psychiatry. 2023;95:342&#x2013;347. doi: 10.1136/jnnp-2023-332073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2023-332073</ArticleId><ArticleId IdType="pubmed">37857497</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M.L., Zegers F.D., Jolving L.R., Knudsen T., Stenager E., Norgard B.M. Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study. Mult. Scler. Relat. Disord. 2023;79:105031. doi: 10.1016/j.msard.2023.105031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2023.105031</ArticleId><ArticleId IdType="pubmed">37778157</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway S.E., Healy B.C., Zurawski J., Severson C., Kaplan T., Stazzone L., Galetta K., Chitnis T., Houtchens M.K. COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders. Mult. Scler. Relat. Disord. 2022;63:103946. doi: 10.1016/j.msard.2022.103946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2022.103946</ArticleId><ArticleId IdType="pmc">PMC9556032</ArticleId><ArticleId IdType="pubmed">35709663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadidchi R., Wang S.H., Rezko D., Henry S., Coyle P.K., Duong T.Q. SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population. Mult. Scler. Relat. Disord. 2024;86:105613. doi: 10.1016/j.msard.2024.105613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2024.105613</ArticleId><ArticleId IdType="pubmed">38608516</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E.E., Kumar S., Rajji T.K., Pollock B.G., Mulsant B.H. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer&#x2019;s Disease and Related Dementias. Am. J. Geriatr. Psychiatry. 2020;28:712&#x2013;721. doi: 10.1016/j.jagp.2020.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.04.010</ArticleId><ArticleId IdType="pmc">PMC7165101</ArticleId><ArticleId IdType="pubmed">32331845</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T., Lolli V., Sadeghi N., Rovai A., Trotta N., Taccone F.S., Creteur J., Henrard S., Goffard J.C., Dewitte O., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95:e2016&#x2013;e2027. doi: 10.1212/WNL.0000000000010116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010116</ArticleId><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Boruah A.P., Thakur K.T., Gadani S.P., Kothari K.U., Chomba M., Guekht A., Heydari K., Hoo F.K., Hwang S., Michael B.D., et al. Pre-existing neurological conditions and COVID-19 co-infection: Data from systematic reviews, meta-analyses, and scoping reviews. J. Neurol. Sci. 2023;455:120858. doi: 10.1016/j.jns.2023.120858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2023.120858</ArticleId><ArticleId IdType="pmc">PMC10751535</ArticleId><ArticleId IdType="pubmed">37948972</ArticleId></ArticleIdList></Reference><Reference><Citation>Eligulashvili A., Gordon M., Lee J.S., Lee J., Mehrotra-Varma S., Mehrotra-Varma J., Hsu K., Hilliard I., Lee K., Li A., et al. Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment. PLoS Med. 2024;21:e1004263. doi: 10.1371/journal.pmed.1004263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004263</ArticleId><ArticleId IdType="pmc">PMC10994395</ArticleId><ArticleId IdType="pubmed">38573873</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Qian J., Wang Y., Wang J., Mi X., Qu L., Song N., Xie J. Potential convergence of olfactory dysfunction in Parkinson&#x2019;s disease and COVID-19: The role of neuroinflammation. Ageing Res. Rev. 2024;97:102288. doi: 10.1016/j.arr.2024.102288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2024.102288</ArticleId><ArticleId IdType="pubmed">38580172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougea A., Georgakopoulou V.E., Palkopoulou M., Efthymiopoulou E., Angelopoulou E., Spandidos D.A., Zikos P. New-onset non-motor symptoms in patients with Parkinson&#x2019;s disease and post-COVID-19 syndrome: A prospective cross-sectional study. Med. Int. 2023;3:23. doi: 10.3892/mi.2023.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mi.2023.83</ArticleId><ArticleId IdType="pmc">PMC10192951</ArticleId><ArticleId IdType="pubmed">37214229</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss M., Gutzeit J., Appel K.S., Bahmer T., Beutel M., Deckert J., Fricke J., Hanss S., Hettich-Damm N., Heuschmann P.U., et al. Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort study. J. Affect. Disord. 2024;352:296&#x2013;305. doi: 10.1016/j.jad.2024.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2024.02.041</ArticleId><ArticleId IdType="pubmed">38360365</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 7 February 2022)].  Available online:  https://news.cuanschutz.edu/cctsi/nationwide-study-of-long-covid-to-launch-at-university-of-colorado-anschutz-medical-campus.</Citation></Reference><Reference><Citation>National Research Action Plan on Long COVID.  [(accessed on 1 August 2022)]; Available online:  https://www.covid.gov/sites/default/files/documents/National-Research-Action-Plan-on-Long-COVID-08012022.pdf.</Citation></Reference><Reference><Citation>Samudyata, Oliveira A.O., Malwade S., Rufino de Sousa N., Goparaju S.K., Gracias J., Orhan F., Steponaviciute L., Schalling M., Sheridan S.D., et al. SARS-CoV-2 promotes microglial synapse elimination in human brain organoids. Mol. Psychiatry. 2022;27:3939&#x2013;3950. doi: 10.1038/s41380-022-01786-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9533278</ArticleId><ArticleId IdType="pubmed">36198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Adult Stem Cell Therapy for COVID-19 Sequelae Begins in Japan for the First Time in the World.  [(accessed on 8 December 2022)].  Available online:  https://www.einpresswire.com/article/532284733/adult-stem-cell-therapy-for-covid-19-sequelae-begins-in-japan-for-the-first-time-in-the-world.</Citation></Reference><Reference><Citation>Ra J.C., Shin I.S., Kim S.H., Kang S.K., Kang B.C., Lee H.Y., Kim Y.J., Jo J.Y., Yoon E.J., Choi H.J., et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20:1297&#x2013;1308. doi: 10.1089/scd.2010.0466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2010.0466</ArticleId><ArticleId IdType="pubmed">21303266</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S., Marking U., Svensson J., Greilert-Norin N., Bacchus P., Nilsson P., Hober S., Gordon M., Blom K., Klingstrom J., et al. Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection. N. Engl. J. Med. 2022;387:1333&#x2013;1336. doi: 10.1056/NEJMc2209651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2209651</ArticleId><ArticleId IdType="pmc">PMC9511632</ArticleId><ArticleId IdType="pubmed">36103621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Jang S.S., Lin H.C., Ma Y., Khanwalkar A.R., Thai A., Patel Z.M. Use of platelet-rich plasma for COVID-19-related olfactory loss: A randomized controlled trial. Int. Forum Allergy Rhinol. 2023;13:989&#x2013;997. doi: 10.1002/alr.23116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.23116</ArticleId><ArticleId IdType="pmc">PMC9877663</ArticleId><ArticleId IdType="pubmed">36507615</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T., Trudler D., Oh C.K., Lipton S.A. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer&#x2019;s Disease, Parkinson&#x2019;s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants. 2022;11:124. doi: 10.3390/antiox11010124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010124</ArticleId><ArticleId IdType="pmc">PMC8772720</ArticleId><ArticleId IdType="pubmed">35052628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha V. Colchicine for Long COVID.  [(accessed on 8 December 2022)].  Available online:  https://www.georgeinstitute.org/projects/Colchicine-for-Long-COVID.</Citation></Reference><Reference><Citation>Could Low-Dose Lithium Treat Long COVID? UB Launches Clinical Trial to Find Out.  [(accessed on 6 January 2023)].  Available online:  https://www.buffalo.edu/news/releases/2023/01/002.html.</Citation></Reference><Reference><Citation> [(accessed on 7 March 2024)]; Available online:  https://ncats.nih.gov/research/research-activities/n3c.</Citation></Reference><Reference><Citation> [(accessed on 7 February 2024)].  Available online:  https://recovercovid.org.</Citation></Reference><Reference><Citation>Effect of Lithium Therapy on Long COVID Symptoms.  [(accessed on 16 November 2022)]; Available online:  https://www.clinicaltrials.gov/ct2/show/NCT05618587?term=Guttuso&amp;cond=Long+COVID&amp;draw=2&amp;rank=1.</Citation></Reference><Reference><Citation>Saunders C., Sperling S., Bendstrup E. A new paradigm is needed to explain long COVID. Lancet Respir. Med. 2023;11:e12&#x2013;e13. doi: 10.1016/S2213-2600(22)00501-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00501-X</ArticleId><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagherazzi G., Zhang L., Elbeji A., Higa E., Despotovic V., Ollert M., Aguayo G.A., Nazarov P.V., Fischer A. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study. PLoS Digit. Health. 2022;1:e0000112. doi: 10.1371/journal.pdig.0000112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pdig.0000112</ArticleId><ArticleId IdType="pmc">PMC9931359</ArticleId><ArticleId IdType="pubmed">36812535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J.J., Bileck A., Hagn G., Meier-Menches S.M., Frey T., Kaempf A., Hollenstein M., Shoumariyeh T., Skos L., Reiter B., et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26:105717. doi: 10.1016/j.isci.2022.105717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchler T., Gunthner R., Ribeiro A., Hausinger R., Streese L., Wohnl A., Kesseler V., Negele J., Assali T., Carbajo-Lozoya J., et al. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation. Angiogenesis. 2023;26:547&#x2013;563. doi: 10.1007/s10456-023-09885-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09885-6</ArticleId><ArticleId IdType="pmc">PMC10542303</ArticleId><ArticleId IdType="pubmed">37507580</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., Metaxaki M., Wills M.R., Sithole N. Reduced Incidence of Long Coronavirus Disease Referrals to the Cambridge University Teaching Hospital Long Coronavirus Disease Clinic. Clin. Infect. Dis. 2023;76:738&#x2013;740. doi: 10.1093/cid/ciac630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac630</ArticleId><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard S.A., Pollett S.D., Fries A.C., Berjohn C.M., Maves R.C., Lalani T., Smith A.G., Mody R.M., Ganesan A., Colombo R.E., et al. Persistent COVID-19 Symptoms at 6 Months after Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection. JAMA Netw. Open. 2023;6:e2251360. doi: 10.1001/jamanetworkopen.2022.51360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer C.D., Scallan C.D., Kraemer Tardif L.D., Kachura M.A., Rappaport A.R., Koralek D.O., Uriel A., Gitlin L., Klein J., Davis M.J., et al. GRT-R910: A self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for &gt;/=6 months in previously-vaccinated older adults. Nat. Commun. 2023;14:3274. doi: 10.1038/s41467-023-39053-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39053-9</ArticleId><ArticleId IdType="pmc">PMC10242235</ArticleId><ArticleId IdType="pubmed">37280238</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 10 May 2024)].  Available online:  https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801464.</Citation></Reference><Reference><Citation> [(accessed on 10 May 2024)].  Available online:  https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30527-0/fulltext.</Citation></Reference><Reference><Citation> [(accessed on 10 May 2024)].  Available online:  https://www.medsci.cn/article/show_article.do?id=05efe63394a4.</Citation></Reference><Reference><Citation>Calcaterra V., Zanelli S., Foppiani A., Verduci E., Benatti B., Bollina R., Bombaci F., Brucato A., Cammarata S., Calabr&#xf2; E., et al. Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach. Diseases. 2024;12:95. doi: 10.3390/diseases12050095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases12050095</ArticleId><ArticleId IdType="pmc">PMC11120262</ArticleId><ArticleId IdType="pubmed">38785750</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinopoli A., Sciurti A., Isonne C., Santoro M.M., Baccolini V. The Efficacy of Multivitamin, Vitamin A, Vitamin B, Vitamin C, and Vitamin D Supplements in the Prevention and Management of COVID-19 and Long-COVID: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2024;16:1345. doi: 10.3390/nu16091345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16091345</ArticleId><ArticleId IdType="pmc">PMC11085542</ArticleId><ArticleId IdType="pubmed">38732592</ArticleId></ArticleIdList></Reference><Reference><Citation>Rymaniak J., Davidavi&#x10d;ien&#x117; V., Lis K. The Basics of Home Office (Re)institutionalisation from the Perspective of Experiences from the COVID-19 Era. Sustainability. 2024;16:3606. doi: 10.3390/su16093606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su16093606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.-J., Park Y.-S., Kim T., Choi H.-H., Yoon Y.-s., Jeon T.-w., Um N. An Improved Strategy to Effectively Manage Healthcare Waste after COVID-19 in Republic of Korea. Sustainability. 2024;16:2696. doi: 10.3390/su16072696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su16072696</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Wang Y., Cui L., Singh R.K., Liu H., Song X., Xu Z., Cui X. Exploring the evolving landscape of COVID-19 interfaced with livelihoods. Humanit. Soc. Sci. Commun. 2023;10:908. doi: 10.1057/s41599-023-02391-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-023-02391-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Manhas K.P., Horlick S., Krysa J., Kovacs Burns K., Brehon K., Laur C., Papathanassoglou E., Ho C. Implementation of a Provincial Long COVID Care Pathway in Alberta, Canada: Provider Perceptions. Healthcare. 2024;12:730. doi: 10.3390/healthcare12070730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12070730</ArticleId><ArticleId IdType="pmc">PMC11011656</ArticleId><ArticleId IdType="pubmed">38610152</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>